FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

STAQ Pharma FentaNYL Citrate PF Recall

FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syrin…

STAQ Pharma, Inc. · Denver, CO

Risk level
Class III
Reported by FDA
Oct 22, 2025
Recall ID
D-0025-2026
Check your lot numberHow we source this data

Summary

STAQ Pharma recalled FentaNYL Citrate PF starting Oct 9, 2025. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0025-2026 on Oct 22, 2025. Reason: Labeling: Incorrect or Missing Lot and/or Exp Date. Status: Ongoing.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date

Product description

FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0102-05.

Lot numbers, UPCs & expiration codes

Lot: 25102464B, Expiry: 26NOV2025; 25102370A, Expiry: 20OCT2025; 25102369A, Expiry: 19OCT2025.

Where it was sold

Nationwide in the U.S.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0025-2026
Classification
Class III
Status
Ongoing
Recall initiated
Oct 9, 2025
FDA report date
Oct 22, 2025
Recall type
Voluntary: Firm initiated
Recalling firm
STAQ Pharma, Inc.

Original FDA data

Every field from FDA enforcement report D-0025-2026, exactly as published.

Show all FDA fields
City
Denver
State
CO
Status
Ongoing
Country
United States
Event ID
97779
Address
14135 E 42nd Ave Ste 50
Code information
Lot: 25102464B, Expiry: 26NOV2025; 25102370A, Expiry: 20OCT2025; 25102369A, Expiry: 19OCT2025.
Postal code
80239-5214
Report date
Oct 22, 2025
Product type
Drugs
Recall number
D-0025-2026
Classification
Class III
Recalling firm
STAQ Pharma, Inc.
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date
Voluntary / mandated
Voluntary: Firm initiated
Product description
FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0102-05.
Distribution pattern
Nationwide in the U.S.
Recall initiation date
Oct 9, 2025
Initial firm notification
Letter
Center classification date
Oct 15, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0025-2026, published Oct 22, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls